Ironwood Pharmaceuticals, Inc. - Class A
Symbol: IRWD (NASDAQ)
Company Description:
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
- Today's Open: $1.08
- Today's High: $1.155
- Today's Low: $1.065
- Today's Volume: 1.31M
- Yesterday Close: $1.11
- Yesterday High: $1.14
- Yesterday Low: $1.1
- Yesterday Volume: 647.13K
- Last Min Volume: 1
- Last Min High: $1.154
- Last Min Low: $1.138
- Last Min VWAP: $1.138
- Name: Ironwood Pharmaceuticals, Inc. - Class A
- Website: https://www.ironwoodpharma.com
- Listed Date: 2010-02-03
- Location: BOSTON, MA
- Market Status: Active
- CIK Number: 0001446847
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $183.55M
- Round Lot: 100
- Outstanding Shares: 162.43M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-03 | 8-K | View |
2025-08-15 | SCHEDULE 13G/A | View |
2025-08-13 | 4 | View |
2025-08-13 | 4 | View |
2025-08-13 | 4 | View |
2025-08-13 | 4 | View |
2025-08-12 | SCHEDULE 13G | View |
2025-08-11 | 10-Q | View |
2025-08-08 | 144 | View |
2025-08-08 | 144 | View |
2025-08-08 | 144 | View |
2025-08-07 | 8-K | View |
2025-07-10 | 8-K | View |
2025-07-07 | SCHEDULE 13G/A | View |
2025-06-17 | 4 | View |
2025-06-12 | 4 | View |
2025-06-12 | 4 | View |
2025-06-12 | 4 | View |
2025-06-12 | 4 | View |
2025-06-12 | 4 | View |